DRMRC
About Us
DE ROTHSCHILD MEDICAL AND RESEARCH CENTRE (DRMRC.COM) L.P. is a distinguished medical research and biotechnology institution, established in 2012 and headquartered at 108 Hatherley Court, Hatherley Grove, London, W2 5RG, United Kingdom. Founded by Dr. Vladimir Levy (MD, PhD), a visionary medical doctor and research scientist, the Centre was created with the mission of advancing global health through cutting-edge medical research and pharmaceutical innovation.
As a limited liability partnership, DRMRC has built a reputable presence in the global medical landscape, with more than a decade of collaboration with government bodies, private institutions, and international research networks. Our core mission is the identification, validation, and clinical trial testing of potent biomaterials—natural or synthetic substances with proven pharmacological properties—sourced from certified vendors and partners around the world.
These biomaterials undergo rigorous clinical evaluations at DRMRC and are then supplied to pharmaceutical manufacturers to support the development of life-saving drugs, particularly those targeting terminal and hard-to-treat diseases such as cancer, autoimmune disorders, neurodegenerative conditions, and rare infections.
Over the years, DRMRC has evolved into a leading commercial supplier and strategic research partner for pharmaceutical and biotech companies worldwide. Our commitment to excellence in research ethics, quality assurance, and innovative solutions has earned us prestigious industry recognitions and accolades, affirming our impact on the global healthcare ecosystem.
With a vision grounded in scientific integrity, global collaboration, and the advancement of human health, DE ROTHSCHILD MEDICAL AND RESEARCH CENTRE continues to pave the way for the next generation of therapeutic discoveries—bringing hope and healing to millions around the world.